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Background
Silymarin, an extract of Silybum marianum seeds, pos-
sesses a broad spectrum of action: antifibrotic, antiin-
flammatory, lipid peroxidation-inhibiting and free
radical-scavenging effects. It is a complex of five major
compounds, and silibinin is the most biologically active
component of the complex. The aim of this study was to
investigate, evaluate and confirm the potential antioxida-
tive effects of silymarin rich in silibinin.
Methods
White laboratory rats of Wistar type were used in this
experiment. They were treated with saline, 1 ml/kg, orally;
olive oil 1 ml/kg, orally; silymarin, 60 mg/kg, orally, every
day; with doxorubicin, 1.66 mg/kg, intraperitoneally, every
second day; and with the combination of silymarin and
doxorubicin in the stated doses. The animals were anaes-
thetised with urethane and a prepared jugular vein was
connected to an infusion pump with verapamil in the
course of recording an electrocardiogram. Then, animals
were sacrificed by cardiopunction and blood samples were
taken to determine serum enzymes activity.
Results
The results show that the treatment with silymarin and
doxorubicin in combination causes statistically significant
increase of the verapamil dose necessary to produce first
change (2.21:0.62, p < 0.01); continuous reaction (2.77:1.5,
p < 0.05) and toxic effect (3.38:1.87, p < 0.05) in compari-
son to the groups treated with doxorubicin alone. The
administration of silymarin prevented an increase of crea-
tine kinase activity induced by doxorubicin (279:616; p <
0.01). The activity of lactate dehydrogenase was not
significantlly different between groups. Silymarin also pre-
vented the doxorubicin-induced increase in aspartate ami-
notransferase activity (349.5:279.5, p < 0.05).
Concusions
On the basis of the results it can be concluded that pro-
oxidative activity of doxorubicin is significantly lower
when it is administered in combination with silymarin.
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